Teijin to offer pricey iPS cell creation, storage service to public
Japan Launches “Just-in-Case” Stem Cell Storage Service: A Glimpse into the Future of Regenerative Medicine A new service launching in April will allow individuals in Japan to proactively store induced pluripotent stem (iPS) cells created from their own blood, offering a potential resource for future medical needs. This “just-in-case” approach, spearheaded by Teijin Regenet Co. … Read more